THE MYASTHENIA GRAVIS INEBILIZUMAB TRIAL (MINT): DESIGN OF RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF AN ANTI-CD19 MONOCLONAL ANTIBODY IN GENERALIZED MYASTHENIA GRAVIS

被引：0
|
作者：
Nowak, R.
Benatar, M.
Ciafaloni, E.
Howard, J.
Leite, M.
Utsugisawa, K.
Vissing, J.
Wu, Y.
Abuhatzira, L.
Katz, E.
Ratchford, J.
机构：
来源：
MUSCLE & NERVE | 2020年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [21] Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG)
    Howard, James
    Barohn, Richard
    Freimer, Miriam
    Juel, Vern
    Mozaffar, Tahseen
    Mellion, Michelle
    Benatar, Michael
    Farrugia, Maria
    Kissel, John
    NEUROLOGY, 2012, 78
  • [22] Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
    Bril, Vera
    Szczudlik, Andrzej
    Vaitkus, Antanas
    Rozsa, Csilla
    Kostera-Pruszczyk, Anna
    Hon, Petr
    Bednarik, Josef
    Tyblova, Michaela
    Koehler, Wolfgang
    Toomsoo, Toomas
    Nowak, Richard J.
    Mozaffar, Tahseen
    Freimer, Miriam L.
    Nicolle, Michael W.
    Magnus, Tim
    Pulley, Michael T.
    Rivner, Michael
    Dimachkie, Mazen M.
    Distad, B. Jane
    Pascuzzi, Robert M.
    Babiar, Donna
    Lin, Jiang
    Querolt Coll, Montse
    Griffin, Rhonda
    Mondou, Elsa
    NEUROLOGY, 2023, 100 (07) : E671 - E682
  • [23] PRELIMINARY-RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JA
    PHILLIPS, JT
    GREENLEE, RG
    WELLS, L
    BELENDIUK, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (12): : 719 - 724
  • [24] A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF AMIFAMPRIDINE PHOSPHATE IN PATIENTS WITH MUSK ANTIBODY POSITIVE MYASTHENIA GRAVIS
    Iyadurai, Stanley
    Buettner, Christian
    MUSCLE & NERVE, 2019, 60 : S136 - S136
  • [25] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Kaminski, Henry
    Benoit, Patrick
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S47 - S48
  • [26] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Nicholson, Katharine
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S127 - S128
  • [27] Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
    Howard, James F., Jr.
    Bril, Vera
    Burns, Ted M.
    Mantegazza, Renato
    Bilinska, Malgorzata
    Szczudlik, Andrzej
    Beydoun, Said
    De Rivera Garrido, Francisco Javier Rodriguez
    Piehl, Fredrik
    Rottoli, Mariarosa
    Van Damme, Philip
    Tuan Vu
    Evoli, Amelia
    Freimer, Miriam
    Mozaffar, Tahseen
    Ward, E. Sally
    Dreier, Torsten
    Ulrichts, Peter
    Verschueren, Katrien
    Guglietta, Antonio
    de Haard, Hans
    Leupin, Nicolas
    Verschuuren, Jan J. G. M.
    Claeys, Kristl
    Diez-Tejedor, Exuperio
    Mathew, Veena
    Sgarzi, Manlio
    Harvey, Brittany Leigh
    Farias, Jerrica
    Frangiomore, Rita
    Heintzman, Sarah
    de Meel, Robert
    Chopra, Manisha
    Alboini, Paolo Emilio
    Hietala, Albert
    Genge, Angela
    NEUROLOGY, 2019, 92 (23) : E2661 - E2673
  • [28] Nocebo In Myasthenia Gravis: A Systematic Review And Meta-Analysis Of Randomized Placebo-Controlled Trials
    Varma, Adithya
    Zis, Panagiotis
    NEUROLOGY, 2019, 92 (15)
  • [29] ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY
    Bril, Vera
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Bozorg, Ali
    Gayfieva, Maryam
    Woltering, Franz
    Kaminski, Henry
    MUSCLE & NERVE, 2022, 66 : S112 - S112
  • [30] Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
    GomezMancilla, Baltazar
    Meriggioli, Matthew N.
    Genge, Angela
    Roubenoff, Ronenn
    Espie, Pascal
    Dupuy, Cyrielle
    Hartmann, Nicole
    Pezous, Nicole
    Kinhikar, Arvind
    Tichy, Mia
    Dionne, Annie
    Vissing, John
    Andersen, Henning
    Schoser, Benedikt
    Meisel, Andreas
    Jordan, Berit
    Devlikamova, Farida
    Poverennova, Irina
    Stuchevskaya, Fatima
    Lin, Thy-Sheng
    Rush, James S.
    Gergely, Peter
    JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 119 : 76 - 84
12345